Bosch to Launch New Capsule Filling Machine
At this year’s Achema, Bosch Packaging Technology will launch its new capsule filling machine, the GKF 2600. This high-performance machine doses powders, pellets, tablets and liquids, as well as combinations precisely and reliably. An output of up to 2600 capsules/ minute can be achieved. “The newly developed GKF 2600 combines proven and new technologies at higher outputs,” Karl-Heinz Kappes, product manager at Bosch Packaging Technology, underlines. “The machine is equipped with new filling technologies for different products, an optimized drive concept, significantly enhanced sensor technology for process control, as well as a demand-oriented containment concept.” Due to its extended machine platform and very good accessibility, the capsule filling machine can be adapted to fill different products in a very short time. Thanks to these characteristics, add-on modules can also be integrated quickly and easily.
New Development with Numerous Expansion Possibilities
The development of the new capsule filling machine is consistently based on the demands of the pharmaceutical industry and profits from the long-term experience of Bosch in capsule filling operations. “With its standard functions, the GKF 2600 fulfills the industry requirements regarding precise and reliable capsule filling. This includes, for instance, an automatic anti troubleshooting (ASB) function, as well as user-friendly handling with improved accessibility of the filling stations,” says Kappes. The optimized containment with more tightly sealed doors further ensures that the highest hygiene standards are maintained during production.
Apart from the standard functions, numerous options are available, such as the new capsule checkweigher KKE 2600 with enhanced product control. In addition, the GKF 2600 can be upgraded with a feedback loop, which automatically regulates overfilling and underfilling of capsules via tendency control of the KKE. An inspection unit can further be integrated into the capsule filling machine. It conducts weight and quality inspections with x-ray technology and an x-ray sensor. “Reliable micro-dosing of powders is crucial, especially for highly effective products that require an exact medication,” Kappes explains. “The micro-dosing wheel of the GKF 2600 precisely processes products in a filling range of two to 30 mg.” Depending on customer requirements and product characteristics, the capsule filling machine can be upgraded for different containment requirements. “The combination of highly developed standard functions and versatile add-on possibilities makes the GKF 2600 a future-proof solution for a broader product spectrum,” Kappes concludes.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.